Hyperinsulinism in the Neonate

Katherine Lord1, Diva D De León1

  • 1The Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA 19104, USA; Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, 3401 Civic Center Boulevard, Philadelphia, PA 19104, USA.

Clinics in Perinatology
|February 7, 2018
PubMed

Insights

Hyperinsulinism (HI) in infants causes persistent hypoglycemia, risking neurologic damage. Early treatment is vital, and advanced PET scans help distinguish focal from diffuse forms for effective surgical management.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Medicine
  • Molecular Genetics

Background:

  • Persistent hypoglycemia in infants is primarily caused by hyperinsulinism (HI).
  • Neurologic damage risk necessitates prompt recognition and treatment of HI, regardless of transient or permanent forms.
  • Congenital HI, often diazoxide unresponsive, frequently results from inactivating mutations in the β-cell ATP-sensitive potassium (KATP) channel (KATP-HI).

Purpose of the Study:

  • To highlight the critical distinction between diffuse and focal forms of KATP-HI.
  • To emphasize the importance of accurate diagnosis for guiding surgical intervention.
  • To introduce the role of 18-fluoro-L-3,4-dihydroxyphenylalanine PET scans in managing HI.

Main Methods:

  • Review of hyperinsulinism (HI) pathophysiology and clinical presentation.
  • Discussion of diagnostic challenges in differentiating focal and diffuse KATP-HI.
  • Evaluation of the impact of 18-fluoro-L-3,4-dihydroxyphenylalanine PET imaging on surgical planning.

Main Results:

  • KATP-HI presents in both diffuse and focal patterns.
  • Accurate differentiation between focal and diffuse HI dictates surgical outcomes: curative for focal, palliative for diffuse.
  • 18-fluoro-L-3,4-dihydroxyphenylalanine PET scanning enables precise localization of focal lesions.

Conclusions:

  • Effective management of infant hyperinsulinism hinges on distinguishing between focal and diffuse disease.
  • 18-fluoro-L-3,4-dihydroxyphenylalanine PET scanning is a transformative tool for localizing focal KATP-HI.
  • Early and accurate diagnosis improves outcomes and reduces the risk of neurologic sequelae in infants with HI.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...